According to the WeChat account of “Shanghai Drug Administration” on January 8, the State Drug Administration recently approved Shanghai Weimi Medical Technology Co., Ltd.'s “self-expanding aneurysm internal embolizer” innovative product registration application. This is the first Class III innovative medical device approved for marketing in Shanghai in 2026.

According to the WeChat account of “Shanghai Drug Administration” on January 8, the State Drug Administration recently approved Shanghai Weimi Medical Technology Co., Ltd.'s “self-expanding aneurysm internal embolizer” innovative product registration application. This is the first Class III innovative medical device approved for marketing in Shanghai in 2026.